KRSA NASDAQ
Korsana Biosciences, Inc.
1W: -8.1%
YTD: +9.8%
$31.91
+7.34 (+29.91%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$149.4M
52W Range—
Volume113,783
Avg Volume7,365
Beta1.75
Dividend—
Analyst Ratings
Company Info
CEORegina Graul
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2026-09-09
Websitecyclerion.com
450 Bedford Street
Cambridge, MA 02420
US
Cambridge, MA 02420
US
About Korsana Biosciences, Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Pernice Michelle Pat | A-Award | 48,445 | $26.20 | 2026-09-09 |
| Shah Nimish P | A-Award | 48,445 | $26.20 | 2026-09-09 |
| Fairmount Funds Mana | A-Award | 48,445 | $26.20 | 2026-09-09 |
| Gottesdiener Andrew | A-Award | 48,445 | $26.20 | 2026-09-09 |
| Violin Jonathan | 0 | — | 2026-09-08 |